» Articles » PMID: 1556186

Nitric Oxide and Angiotensin II. Glomerular and Tubular Interaction in the Rat

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1992 Apr 1
PMID 1556186
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO) has been proposed to modulate the renal response to protein as well as basal renal hemodynamics. We investigated whether NO and angiotensin II (AII) interact to control glomerular hemodynamics and absolute proximal tubular reabsorption (APR) during glycine infusion and in unstimulated conditions. In control rats, glycine increased single nephron GFR and plasma flow with no change in APR. The NO synthase blocker, NG-monomethyl L-arginine (LNMMA), abolished the vasodilatory response to glycine, possibly through activation of tubuloglomerular feedback due to a decrease in APR produced by LNMMA + glycine. Pretreatment with an AII receptor antagonist, DuP 753, normalized the response to glycine at both glomerular and tubular levels. In unstimulated conditions, LNMMA produced glomerular arteriolar vasoconstriction, decreased the glomerular ultrafiltration coefficient, and reduced single nephron GFR. These changes were associated with a striking decrease in APR. DuP 753 prevented both glomerular and tubular changes induced by LNMMA. In conclusion, NO represents a physiological antagonist of AII at both the glomerulus and tubule in both the basal state and during glycine infusion; and inhibition of NO apparently enhances or uncovers the inhibitory effect of AII on proximal reabsorption.

Citing Articles

Intravenous amino acid for kidney protection: current understanding and future perspectives.

Kotani Y, Baiardo Redaelli M, Pruna A, Losiggio R, Cocozza S, Ti L Clin Kidney J. 2025; 18(2):sfae409.

PMID: 39981140 PMC: 11840255. DOI: 10.1093/ckj/sfae409.


Diabetic Nephropathy and Gaseous Modulators.

Juin S, Ouseph R, Gondim D, Jala V, Sen U Antioxidants (Basel). 2023; 12(5).

PMID: 37237955 PMC: 10215699. DOI: 10.3390/antiox12051088.


The role of nitric oxide in sepsis-associated kidney injury.

Moreira Borges Oliveira F, Assreuy J, Sordi R Biosci Rep. 2022; 42(7).

PMID: 35722824 PMC: 9274646. DOI: 10.1042/BSR20220093.


Role of Rho in Salt-Sensitive Hypertension.

Kawarazaki W, Fujita T Int J Mol Sci. 2021; 22(6).

PMID: 33803946 PMC: 8001214. DOI: 10.3390/ijms22062958.


Kidney and epigenetic mechanisms of salt-sensitive hypertension.

Kawarazaki W, Fujita T Nat Rev Nephrol. 2021; 17(5):350-363.

PMID: 33627838 DOI: 10.1038/s41581-021-00399-2.


References
1.
Alvestrand A, Zimmerman L, Bergstrom J . Potential role of a liver-derived factor in mediating renal response to protein. Blood Purif. 1988; 6(5):276-84. DOI: 10.1159/000169555. View

2.
Anderson S, Meyer T, Rennke H, Brenner B . Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985; 76(2):612-9. PMC: 423867. DOI: 10.1172/JCI112013. View

3.
Hirschberg R, Zipser R, Slomowitz L, Kopple J . Glucagon and prostaglandins are mediators of amino acid-induced rise in renal hemodynamics. Kidney Int. 1988; 33(6):1147-55. DOI: 10.1038/ki.1988.123. View

4.
Castellino P, Coda B, DeFronzo R . Effect of amino acid infusion on renal hemodynamics in humans. Am J Physiol. 1986; 251(1 Pt 2):F132-40. DOI: 10.1152/ajprenal.1986.251.1.F132. View

5.
HIRSCHBERG R, Kopple J . Role of growth hormone in the amino acid-induced acute rise in renal function in man. Kidney Int. 1987; 32(3):382-7. DOI: 10.1038/ki.1987.221. View